Skip to Main ContentSkip to FooterSkip to Search
  1. Home
  2.  » 
  3. Expert Content
  4.  » 
  5. Biologics Analytical Services
  6.  » Endpoints 11 – BioPharma’s Most Promising Startups in 2021

Endpoints 11 – BioPharma’s Most Promising Startups in 2021

Summary: An extraordinary ferment of scientific activity over the last 20 years has spawned a new generation of biotech companies, dedicated to the pursuit of breakthrough therapies and the creation of important new pipelines. This will be Endpoints’ 2021 look at 11 of the most important up-and-coming private biotechs in the business, independently selected by company founder and editor John Carroll. Watch as he and Catalent’s Chairman & CEO, John Chiminski talk biotech with the teams behind the winning companies and learn what defines the Endpoints 11, followed up with a fireside chat with two trendsetting VCs who have helped sponsor some of the leading startups in the field.

Click here to download the Webinar